Genprex
-$0.17 (-5.26%) Today
+$0.06 (+1.86%) As of 9:18 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genprex and other ETFs, options, and stocks.
About GNPX
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer.
CEO
J. Rodney Varner
Employees
12
Headquarters
Austin, Texas
Founded
2009
GNPX Key Statistics
Market Cap
176.64M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
481.08K
High Today
$3.23
Low Today
$3.05
Open Price
$3.18
Volume
275.47K
52 Week High
$7.72
52 Week Low
$2.80
GNPX Earnings
-$0.14
-$0.09
-$0.05
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, Pre-Market